RECURRENCE OF HEMOLYTIC UREMIC SYNDROME AFTER RENAL TRANSPLANTATION IN CHILDREN

Abstract

The risk of HUS recurrence in the allograft is 8-9% and is heightened in atypical HUS. Treatment was not effective and graft outcome was poor. Cyclosporine does not affect HUS recurrence.